Research on health literacy for the patient who is expected to test by Comprehensive Genomic Profiling

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1030210390

Enrollment

300

Registered

2021-10-26

Start date

2021-10-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplasm neoplasm

Interventions

Pharmacists provide information to patients about Comprehensive Genomic Profiling when they receive chemotherapy.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Inpatients and outpatients who received chemotherapy in our hospital 2) Patients who received health insurance treatment at the time of selection 3) Patients who is expected to test by Comprehensive Genomic Profiling 4) Patients who are older than 20 years old at the time of informed consent 5) Patients who agree to participate in this study

Exclusion criteria

Exclusion criteria: 1) Patients who has difficulty for decision to particiate in this study by themselves 2) Any other patients that the researcher considers inappropriate for participation

Design outcomes

Primary

Measure	Time frame
Decisional Conflict Scale	—

Secondary

Measure	Time frame
factors affecting DCS	—

Contacts

Public ContactOrie Hatakeyama

Juntendo University Hospital

osaigo@juntendo.ac.jp+81-3-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026